Healthcare
United Kingdom
Enterprise/Public Sector
"Working closely with Alibaba Cloud, we managed to harness the benefits of the Qwen LLM and Dedicated Model Studio and vastly improved the efficiency of generating adverse event reports from huge amounts of medical literature. We’re proud that we have pioneered this innovation in the industry. We expect to explore more AI-based innovations with Alibaba Cloud."
Xin Zhong
IT head of AstraZeneca China
About AstraZeneca
A global biopharmaceutical company focused on science-led innovation, AstraZeneca aims to transform healthcare by leveraging scientific advancements and emerging technologies. The company integrates data science and AI into its R&D to enhance drug development and understanding of diseases. In 2024, AstraZeneca established a new strategic R&D center in Shanghai, marking a significant step in its global expansion.
Challenges
AstraZeneca has expanded its global presence by establishing R&D centers and manufacturing facilities in China to utilize local capabilities and market opportunities. A key imperative for multinational pharmaceutical companies in China is complying with local regulatory requirements, such as reporting adverse drug reactions (ADR) to the National Medical Products Administration (NMPA). This process is time-consuming for medical researchers, who must gather and analyze medical literature from healthcare professionals and institutions to create reports that meet strict regulatory standards, including specific formatting and editorial guidelines.
Why Alibaba Cloud
Alibaba Group is a key player in digitalization in China and globally, with a strong history of integrating AI across multiple industry sectors. Alibaba Cloud, the technology backbone of the group, plays a significant role in AI-driven innovation in China, supporting over 80% of China's tech businesses and more than 50% of LLM-based innovations. A leading LLM in China and globally, Tongyi Qwen offers various model sizes and multi-modal features, and is ideal for cross-lingual scenarios.
Architecture
Working with Alibaba Cloud, AstraZeneca's team has built the industry’s first adverse event summary system based on Tongyi Qwen LLM and Dedicated Model Studio. The system makes full use of the AI engineering capabilities provided by Alibaba Cloud's Dedicated Model Studio, integrating AstraZeneca's private knowledge bases and publicly available medical and pharmacological knowledge.
With Alibaba Cloud’s AI engineering platform, both development and administration tasks are now more streamlined.
AstraZeneca’s researchers can create tasks and input documents into the system, which generates an adverse event report, based on the source information. The report only needs a human review and minimal edits before sign-off.
Private deployment on the cloud, leveraging Dedicated Model Studio, allows AstraZeneca to leverage the scalability and stability of using the cloud-based solution. This ensures a more stringent data and system segregation, while crucially safeguarding data privacy.
Key Results
Thanks to Alibaba Cloud’s LLM-based system, accuracy of the adverse event reports has increased from 90% to 95%.
As the system can quickly comb through vast amounts of medical literature and formulate output documents according to the requirements, efficiency in creating the adverse event reports has increased by 300%.
Looking Forward
Working with Alibaba Cloud, AstraZeneca has proudly made this pioneering solution the first of its kind in the pharmaceutical industry, which will empower pharmaceutical businesses and enhance safety for patients. The company is looking forward to pioneering more AI-driven innovations, by leveraging its industrial expertise in concert with Alibaba Cloud's cutting-edge technologies for greater digitalization.
Featured Products
Top-performance foundation models from Alibaba Cloud.
A one-stop generative AI platform to build intelligent applications that understand your business, based on Qwen model series such as Qwen-Max and other popular models
Other Related Stories
Futureverse
Futureverse's partnership with Alibaba Cloud has helped them overcome challenges and achieve key results in their pursuit of AI and metaverse technology innovation, their large model training process was significantly optimized and accelerated on Alibaba Cloud's PAI Lingjun AI infrastructure.
Chainbase
By offering a cost-effective and robust hosting solution, Alibaba Cloud enabled Chainbase's rapid expansion and smooth data migration without downtime, halving infrastructure costs and enhancing efficiency and security.
FathomX
FathomX leveraged Alibaba Cloud's advanced solutions to significantly reduce lead times for computational resources, cut infrastructure costs, and enhance its capability to scale and deploy AI-driven medical diagnostic services globally.
Snapshot
Through its partnership with Alibaba Cloud, AstraZeneca has introduced a groundbreaking adverse event summary system in the pharmaceutical industry, utilizing Qwen LLM and Dedicated Model Studio to significantly enhance the accuracy and efficiency of reporting.
Product/Solution Used
View More Solutions
A Free Trial That Lets You Build Big!
Start building with 50+ products and up to 12 months usage for Elastic Compute Service
Get Started for Free Get Started for Free
